Protect Your Workforce with Precision-Driven Risk Assessments
At Indivirtus Healthcare Services, our specialized Occupational Toxicology services deliver comprehensive, science-based risk assessments for pharmaceutical compounds. From deriving precise Occupational Exposure Limits (OELs) to implementing facility-wide exposure control strategies, we combine advanced methodologies with deep regulatory expertise to ensure optimal worker safety and seamless global compliance.
Our Occupational Toxicology service provides comprehensive health risk assessments for pharmaceutical compounds, expertly deriving scientifically defensible exposure limits and developing robust control strategies that protect workers. Using state-of-the-art methodologies, we ensure full compliance with the most stringent global regulatory standards.
High-potency compounds, including cutting-edge modalities like ATMPs and ADCs, can pose serious health risks without proper risk management. Our detailed evaluations identify potential exposure risks, establish safe operational limits, and provide practical, actionable strategies to minimize harm while ensuring complete regulatory compliance.
Indivirtus Healthcare Services combines certified toxicologists with extensive global regulatory expertise to deliver customized, scientifically robust risk assessments. From precise OEL derivation to comprehensive facility-wide risk mapping, we provide evidence-based solutions that safeguard your operations and protect your most valuable asset - your workforce.
At Indivirtus Healthcare Services, we employ a comprehensive, evidence-based approach to assess toxicological risks of pharmaceutical compounds. Our systematic process begins with deriving precise Occupational Exposure Limits (OELs) using carefully analyzed NOAEL/LOAEL data and species-specific allometric scaling to establish accurate, safe exposure thresholds. We calculate Acceptable Daily Exposures (ADEs) for effective cross-contamination control and provide detailed Occupational Exposure Banding (OEB) classifications that align perfectly with established global frameworks.
For innovative modalities like ATMPs, oligonucleotides, and ADCs, we apply specialized risk assessment methodologies specifically designed to address their unique safety challenges. Our experienced team conducts thorough facility-wide risk mapping using proven Failure Modes and Effects Analysis (FMEA) techniques to identify critical exposure points, followed by developing compound-specific control strategies that align seamlessly with ISPE Risk-MaPP and EMA HBEL guidelines. Each comprehensive assessment includes detailed uncertainty analysis and provides clear, actionable implementation roadmaps for engineering controls and PPE strategies, ensuring practical, compliant, and effective solutions.
Detailed OEL/ADE Derivation Report: Comprehensive scientific report with thorough uncertainty analysis for establishing safe exposure limits.
Professional OEB Classification: Band-specific containment recommendations with robust safety measures tailored to your facility.
Facility Risk Assessment Matrix: FMEA-format comprehensive matrix identifying all critical exposure points with prioritized actions.
Cross-Contamination Control Strategy: Detailed strategic document outlining proven methods to prevent contamination risks.
Compound-Specific Safety Data Sheets (SDS): Customized SDS documents for safe handling procedures and regulatory compliance.
Toxicological Data Gap Analysis: Thorough identification of data gaps (when applicable) to guide future studies and assessments.
Regulatory Submission-Ready Summaries: Professional toxicology summaries formatted for seamless regulatory submissions.
Our Occupational Toxicology services strictly adhere to the most stringent global regulatory guidelines, ensuring your risk assessments are scientifically robust, legally defensible, and audit-ready. By aligning with industry-leading international standards, we help you achieve seamless compliance across global markets, safeguarding worker safety while maintaining operational excellence and regulatory integrity.
Our Occupational Toxicology services are essential for pharmaceutical manufacturers working with high-potency compounds, innovative modalities, or hazardous substances. Whether you need precise OELs/ADEs derivation, professional compound classification under OEB frameworks, or comprehensive facility-wide exposure control plans, our services ensure optimal safety and regulatory compliance. Key applications include thorough risk assessments for new drug development programs, strategic cross-contamination control in shared manufacturing facilities, and ensuring complete compliance during regulatory audits conducted by agencies like the FDA, EMA, or other global regulatory bodies.
Indivirtus Healthcare Services uniquely combines the expertise of certified toxicologists with extensive global regulatory knowledge to deliver unmatched Occupational Toxicology solutions. Our scientifically rigorous approach ensures defensible results, rapid turnaround times, and strict confidentiality protocols to protect your proprietary data. With customized risk assessments and practical, actionable control strategies, we help you effectively mitigate risks, achieve seamless regulatory compliance, and ensure the safety and wellbeing of your workforce for sustained operational excellence.
For compounds with limited data, we employ a comprehensive approach: 1) Read-across analysis from structurally similar compounds, 2) Threshold of Toxicological Concern (TTC) methodologies, 3) Pharmacological activity-based estimation techniques, and 4) Expert professional judgment with conservative uncertainty factors - always providing clear documentation of data gaps and underlying assumptions.
For genotoxic compounds, we follow a structured tiered approach: 1) Apply TTC-based limits (1.5μg/day) when no threshold can be scientifically identified, 2) Use linear extrapolation from TD50 when relevant data exists, and 3) Consider threshold approaches when robust mechanistic data supports it. All recommendations include comprehensive ALARP (As Low As Reasonably Practicable) implementation guidance.
Yes, we specialize in creating harmonized approaches that fully meet EMA HBEL requirements for cross-contamination control while also satisfying OSHA and ACGIH expectations for occupational safety, often developing compound-specific 'control bands' that efficiently address both regulatory requirements.
For ATMPs, we modify traditional approaches by: 1) Evaluating replicative capacity rather than classic toxicity endpoints, 2) Considering patient-specific risks (autologous vs allogeneic therapies), and 3) Developing facility controls based on biological containment principles (BSL levels) in addition to traditional chemical exposure paradigms.
Our standard deliverables include both comprehensive technical reports (with full methodology and references) and submission-ready modules formatted per CTD requirements, including detailed uncertainty analysis and clear rationale for all derived values suitable for MHRA, FDA, and EMA review processes.
Our comprehensive service includes precise OEL/ADE derivation, professional OEB classification, facility-wide risk mapping using FMEA methodology, strategic cross-contamination control strategies, customized compound-specific SDS, thorough data gap analysis, and regulatory-ready toxicology summaries.
We align with all major regulatory frameworks including EMA HBEL (2014), ICH Q3D (2019), ISPE Risk-MaPP, OSHA 29 CFR 1910.1000, ACGIH TLVs, REACH Regulation, and NIOSH Hazardous Drug Guidelines for comprehensive compliance.
We apply specialized, modified risk assessment methodologies specifically tailored to the unique properties and safety considerations of novel modalities like ATMPs, oligonucleotides, and ADCs, ensuring accurate and highly relevant safety evaluations.
You'll receive detailed OEL/ADE reports, professional OEB classifications, comprehensive FMEA risk matrices, strategic control strategy documents, customized SDS, thorough data gap analyses, and regulatory submission-ready toxicology summaries.
This service is ideal for new drug development programs, cross-contamination control in shared manufacturing facilities, precise OEL/ADE derivation for high-potency compounds, or ensuring complete compliance during regulatory audits and inspections.
We follow strict confidentiality protocols and industry best practices to protect your proprietary data throughout the entire assessment and documentation process, with comprehensive NDAs and secure data handling procedures.